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Space Radiation Program Element
SRPE Integrated Research Plan Meets 
Agency Requirements
Develop & Modify Standards: Cancer PELs, Short-Term/non-cancer (CNS, CVD, 
ARS)
• 4.1.3 The SR shall perform the research necessary to enable the development and 
modification of the SR standards sets documented in NASA - STD- 3001, Vol.1 and Vol. 2.
Risk Characterization & Monitoring:
• 5.1.6 The SR shall qualitatively or quantitatively assess the Space Radiation-applicable 
risks 
• 5.4.5 The SR shall provide evidence to support determination of status for SR-applicable 
concerns  
• 5.3.5 The SR shall develop methods and technologies to monitor indicators of adverse 
outcomes of SR-applicable risks 
Risk Mitigation: Physical and Biomedical Countermeasures
• 5.2.5 The SR shall develop countermeasures and technologies, or provide research 
evidence to inform mission and vehicle requirements, to prevent or mitigate adverse 
outcomes of SR-applicable risks
• 6.4.3 The SR shall develop methods and technologies to reduce human systems resource 
requirements (mass, volume, power, crew time, etc.). 
3From: HRP-47052, HRP Program Requirements Doc
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Space Radiation Program Element 
- Research Strategy
Maintain Balance Across Four Distinct Risk Areas Based on 
Mission Drivers and State-of-Knowledge:
– Meeting Cancer Career PEL is design driver for GCR & SPE shielding, 
mission duration, and crew selection -
• Mission driver: younger female crew have highest risk (highlights importance 
of age and sex dependence)
• By exceeding Cancer PELs & accepting increased risk – begin to exceed 
thresholds for CNS and CVD risks 
– Research with animal models shows changes to the CNS occur at HZE 
exposure levels in range of concern to NASA -
• Significance to morbidity in humans  (in-flight or late) and modification of risk 
by other spaceflight factors not understood
– Evidence for elevation of CVD risk at doses as low as 0.5 Gy -
• Studies of A-bomb survivor data and epidemiology data from occupational 
and medical exposures – which will impact %REID career limits
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Current Portfolio Priority: Cancer, In-flight Central Nervous System 
(CNS), Cardiovascular, Acute Radiation syndromes, Late CNS
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NASA Permissible Exposure Limits 
(PELs)
• Current Radiation PELs are documented in 
NASA Space Flight Human Systems 
Standard Volume 1, Rev A: Crew Health
• PELs are in place to prevent clinically 
significant adverse outcomes and/or limit 
risk to a level that NASA deems acceptable 
to the crew
• PELs are in place to protect against both 
short-term and late health effects
• PELs are important for mission design 
including vehicle design, shielding 
configuration, mission length and crew 
certification for flight
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Congress has chartered the National Council 
on Radiation Protection (NCRP) to guide 
Federal agencies on radiation limits and 
procedures
• NCRP guides NASA on astronaut dose limits
• Basis for current PELs - NCRP Report No. 132 
(2000) Radiation Protection Guidance for Activities 
in Low-Earth Orbit
NASA Permissible Exposure Limits -
Background
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NASA Permissible Exposure Limits -
Cancer
• Less than 1 in 33 chance of early death
• Best estimate is 15-years average life 
loss for space radiation attributable 
cancer
• Confidence level depends on exposure 
type (GCR, SPE)
Based on 1989 comparison of risks in “less-
safe” industries
95% confidence is conservative and is 
intended to account for uncertainties 
inherent in risk projection model – vary from 
50% - <300%
Career exposure to radiation is limited to not exceed 3% risk of 
exposure‐induced death (REID) from fatal cancers, measured at the 95% 
confidence level
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Cancer Risk Assessment – NSCR2012
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Flow chart for REID and REIC calculations
F.A. Cucinotta, M.-H.Y. Kim, and L.J. Chappell. 2011. Space 
Radiation Cancer Risk Projections and Uncertainties—
2010. NASA/TP-2011-216155
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Cancer Risk-to-Dose Relationship 
• The relationship between radiation exposure and risk is age- and sex- specific 
related to latency effects and differences in tissue types, sensitivities, and life-
spans between sexes
• Limits for other career or mission lengths vary and can be calculated using the 
appropriate life-table formalism and projections in risk uncertainties
• The 95th percentile confidence level using uncertainties in risk projections must 
be applied to these values
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Uncertainties in Risk Assessment
Major  Uncertainties in Cancer Risk Model
Durante and Cucinotta, Nature Rev. Cancer, 2008
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• Radiation Quality - Q
• Qualitative and quantitative 
differences between space
radiation compared with x-rays
or gamma rays
• Dose-rate reduction factors
• Dependence of risk on the
dose rates encountered in
space
• Epidemiology data 
• Statistics, Bias, Transfer to US 
population
• Predicting Radiation Environment
• Measurement dosimetry, space 
environment, radiation transport 
models
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Individual Organ and Tissue Contributions 
to Cancer Risk
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For crew members at mid-mission age 47y ISS at 400 km during Solar Minimum Activity
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NASA Unique Research 
Major Sources of Uncertainty in Estimating and 
Mitigating Risks
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Morgan, Health Phys. 2009 
Risk Characterization
Mixed field: GCR Simulation
Blue: NSRL 
collection of 
radiobiology 
data
NASA research
Straume, et al; 2010
Dose Rate Effects 
50% dose
15% dose eq
10% dose
50% dose eq
• Radiation quality effects on biological damage 
− Qualitative and quantitative differences between 
space radiation compared with gamma rays
− Mixed field effect
• Dependence of risk on the dose and dose rates
− Contribution of Non targeted effects
• Synergistic Effects of Spaceflight 
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Limits on Tissue Reactions (Deterministic Effects) 
Short-term or Late Non-cancer Effects
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•Non-cancer risks are considered to be deterministic:
•Both the probability and severity of non-stochastic effects increase with 
dose above a threshold dose where clinical effects can be observed
•Early radiation effects are in general considered to be related to a 
significant fraction of cell loss, occurring above the threshold for functional 
impairment in a tissue
•Short-term dose limits are imposed to prevent clinically significant non-
cancer health effects including performance degradation, sickness, or death in-
flight
•Career dose limits for cataracts, heart disease, and damage to the central 
nervous system are imposed to limit or prevent risks of degenerative tissue 
diseases (e.g., stroke, coronary heart disease, etc.) that occur post-mission
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Limits on Tissue Reactions (Deterministic Effects) 
Short-term or Late Non-cancer Effects
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*Lens limits are intended to prevent early (< 5 yr) severe cataracts (e.g., from a 
solar particle event).   An additional cataract risk exists at lower doses from 
cosmic rays for sub-clinical cataracts, which may progress to severe types after 
long latency (> 5 yr) and are not preventable by existing mitigation measures; 
however, they are deemed an acceptable risk to the program.
**Heart doses calculated as average over heart muscle and adjacent arteries.
***CNS limits should be calculated at the hippocampus.
Current Non-Cancer Dose Limits defined in NASA Standard 3001:
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Limits on Tissue Reactions (Deterministic Effects) 
Short-term or Late Non-cancer Effects
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The Gray-Equivalent based on relative biological effectiveness factors 
(RBEs) are used to calculate the effective doses for non-cancer effects
TT DRBEG 
GT = Tissue specific Gy-Equivalent  
RBE = Relative Biological Effectiveness    
DT= Tissue dose
Note that the RBE for Central Nervous System (CNS) non-cancer effects is largely 
unknown and, therefore, a physical dose limit (mGy) is used 
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Risk of Acute Radiation Syndromes from Solar 
Particle Events
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• Clinical course of ARS are well defined in human populations accidently exposed to acute, 
high doses of gamma- and X-rays
• Symptoms 4 to 48 hours post-exposure for sub-lethal doses with a latency time inversely 
correlated with dose 
• Risk for ARS is low in Low Earth Orbit (LEO) due to protection by Earth’s magnetosphere
• Risk increases beyond LEO Risks where protection by magnetosphere is lost
• SPEs can be effectively shielded; however their occurrence and magnitude are difficult to 
predict
• Uncertainty exists about the magnitude of acute health effects from whole-body exposures 
to protons from an SPE, which are characterized by a high degree of variability in dose 
distribution in the body as well as by dynamic changes in dose-rates and energy spectra
Major Sources of Uncertainty: Dose-rate,  
Inhomogeneous Dose Distribution and Impact of 
Radiation Quality of Protons, combined effects of 
microgravity 
How do these parameters influence the BFO dose 
limits?
Space Radiation Program Element
Current NASA Radiation Short-Term and 
Annual PELs 
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Organ 30 day 1 Year Career
Skin 1500 
mGy-Eq
3000 
mGy-Eq
6000 
mGy-Eq
BFO 250 
mGy-Eq
500 
mGy-Eq
NA
• PELs inform mission design, vehicle shielding and storm shelter 
requirements
The 30-day blood forming organ (BFO) limit is intended to protect the 
hematopoietic system from depletion below a critical limit
• Also, considered to be adequate to project against the risks of symptoms associated 
with the prodromal phase of ARS, such as nausea, vomiting, and fatigue
The 30-day skin limit is intended to protect against late skin complications (dermal 
atrophy, fibrosis, necrosis, telangiectasia)
• Also, considered to be adequate to protect against early, acute skin effects such as 
erythema and desquamation  
Major Sources of Uncertainty: Dose-rate,  
Inhomogeneous Dose Distribution and 
Impact of Radiation Quality of Protons, 
combined effects of microgravity 
How do these parameters influence the 
BFO dose limits?
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Risk of Cardiovascular Disease 
from Space Radiation Exposure
• Recent studies of atomic bomb survivor data and epidemiology data from 
occupational and medical exposures provide evidence for elevation of risk 
at doses as low as 0.5 Gy
‒ Data at low doses is confounded by life-style factors, clouding interpretation 
of epidemiology 
‒ Effects are considered deterministic, with an associated threshold dose; 
however recent evidence showing risk at lower doses questions this 
assumption
• Preliminary risk assessment models are being formulated based on recent 
epidemiology data for lower dose low-LET exposures — future risk 
estimates will depend on high LET research results 
• Additional mortality and morbidity risks for non-cancer diseases of the 
cardiovascular system are of concern  because they could increase REID 
values
• Well documented that exposure to high doses of 
low-LET (>5 Gy) radiation during radiotherapy to 
the chest is associated with increased risk of 
cardiovascular disease later in life
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Image courtesy of NASA
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• Current research is focused on understanding and quantifying the risk of 
cardiovascular disease at space relevant exposures in support of validating 
PELs and development of risk assessment models
- Identify disease spectrum and latency for low dose heavy ions
- Establishing dose thresholds for heavy ions
- Understand qualitative differences between GCR and gamma-rays to 
quantify RBEs
- Dose-rate effects
Cardiovascular Disease from Space Radiation 
Research Focus
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Career limits for the heart are intended to limit risk of death from radiation induced 
for cardiovascular diseases to be below a few percent, and are expected to be 
largely age and gender independent
RBE’s to assess risks/limits for the cardiovascular and CNS are largely unknown – research 
required to inform PELs
Organ 30 day 1 Year Career
Heart 250 
mGy-Eq
500 
mGy-Eq
1000 
mGy-Eq
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• Radiation effects to the CNS are a significant 
risk for long duration exploration class 
missions:
– possibility of acute, in-flight functional 
alterations that negatively impact performance 
– possibility of late neurological pathologies 
such as early onset dementia and other 
neuropsychological changes
• Examples of human behaviors and cognitive 
function of interest that may be affected by 
space flight include memory, learning, spatial 
orientation, motor function, emotion 
recognition, risk decision making, vigilance, 
reaction time, processing speed, circadian 
regulation, fatigue and neuropsychological 
changes.
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Cognitive and Behavioral Central Nervous 
System Risks from Space Radiation
Eating, sleeping and working in space.
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In-flight/Late CNS Effects from Space 
Radiation Research Focus
• Focus on CNS risk definition and characterization
• Understanding whether there are significant risks at space relevant exposures
– Description of the spectrum and severity of possible in-flight cognitive, 
behavioral, and functional changes as well as possible late neurodegenerative 
conditions
– Radiation quality and dose-rate dependencies
– Establish possibility of dose thresholds
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Based on available radiobiology data 
information on relative biological 
effectiveness for CNS risks are highly 
uncertain and therefore CNS dose limits 
are expressed in mGy; with a separate 
limit for heavy ions with elemental 
charge >10 absorbed dose (in mGy)
Organ 30 day 1 Year Career
CNS 500 
mGy
1000 
mGy
1500 
mGy
CNS 
(Z≥10)
100
mGy
250 
mGy
